Endo Launches ADRENALIN® Ready-to-Use Premixed Bag, the First and Only FDA-Approved, Manufacturer-Prepared Epinephrine Premixed IV Bag
MALVERN, Pa. , Dec. 2, 2024 /CNW/ -- Endo, Inc. (OTCQX: NDOI ) announced today the launch of its ADRENALIN ® (epinephrine in 0.9% sodium chloride injection) ready-to-use premixed bag, the first and ...
i49m
My son wasn’t developing – it took six years to find out why
As the NHS explores extended genetic screening for newborns, Paul Dinsdale investigates the perils and pitfalls of genomic ...